BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15497826)

  • 21. Membrane bioreactor operation at short solids retention times: performance and biomass characteristics.
    Ng HY; Hermanowicz SW
    Water Res; 2005 Mar; 39(6):981-92. PubMed ID: 15766953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of polycyclic musks in wastewater and receiving water bodies and fate during wastewater treatment.
    Clara M; Gans O; Windhofer G; Krenn U; Hartl W; Braun K; Scharf S; Scheffknecht C
    Chemosphere; 2011 Feb; 82(8):1116-23. PubMed ID: 21144551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
    Bendz D; Paxéus NA; Ginn TR; Loge FJ
    J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor.
    Radjenovic J; Petrovic M; Barceló D
    Anal Bioanal Chem; 2007 Feb; 387(4):1365-77. PubMed ID: 17115140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge.
    Carballa M; Omil F; Ternes T; Lema JM
    Water Res; 2007 May; 41(10):2139-50. PubMed ID: 17399761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Removal of pharmaceuticals and fragrances in biological wastewater treatment.
    Joss A; Keller E; Alder AC; Göbel A; McArdell CS; Ternes T; Siegrist H
    Water Res; 2005 Sep; 39(14):3139-52. PubMed ID: 16043210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes.
    Sui Q; Huang J; Deng S; Chen W; Yu G
    Environ Sci Technol; 2011 Apr; 45(8):3341-8. PubMed ID: 21428396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fate of aromatic hydrocarbons in Italian municipal wastewater systems: an overview of wastewater treatment using conventional activated-sludge processes (CASP) and membrane bioreactors (MBRs).
    Fatone F; Di Fabio S; Bolzonella D; Cecchi F
    Water Res; 2011 Jan; 45(1):93-104. PubMed ID: 20804998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater.
    Kreuzinger N; Clara M; Strenn B; Vogel B
    Water Sci Technol; 2004; 50(2):221-8. PubMed ID: 15344795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
    Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
    Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants.
    Suárez S; Ramil M; Omil F; Lema JM
    Water Sci Technol; 2005; 52(8):9-14. PubMed ID: 16312946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodegradation of persistent polar pollutants in wastewater: comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment.
    Bernhard M; Müller J; Knepper TP
    Water Res; 2006 Oct; 40(18):3419-28. PubMed ID: 16962630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced membrane bioreactor process without chemical cleaning.
    Krause S; Zimmermann B; Meyer-Blumenroth U; Lamparter W; Siembida B; Cornel P
    Water Sci Technol; 2010; 61(10):2575-80. PubMed ID: 20453330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fate of surfactants in membrane bioreactors and conventional activated sludge plants.
    Gori R; Cammilli L; Petrovic M; Gonzalez S; Barcelò D; Lubello C; Malpei F
    Environ Sci Technol; 2010 Nov; 44(21):8223-9. PubMed ID: 20886831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant.
    Carballa M; Omil F; Lema JM; Llompart M; García-Jares C; Rodríguez I; Gómez M; Ternes T
    Water Res; 2004 Jul; 38(12):2918-26. PubMed ID: 15223286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of sludge structure and activity in submerged membrane bioreactor.
    Spérandio M; Masse A; Espinosa-Bouchot MC; Cabassud C
    Water Sci Technol; 2005; 52(10-11):401-8. PubMed ID: 16459815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane bio-reactor for advanced textile wastewater treatment and reuse.
    Lubello C; Gori R
    Water Sci Technol; 2004; 50(2):113-9. PubMed ID: 15344781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane bioreactor process of organic wastewater from brassylic acid manufacturing plant.
    Wu ZC; Zeng P; Wang SF; Gao TY
    J Environ Sci (China); 2001 Apr; 13(2):157-63. PubMed ID: 11590734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of synthetic musk fragrances in seven wastewater treatment plants of Beijing, China.
    Hu Z; Shi Y; Zhang S; Niu H; Cai Y
    Bull Environ Contam Toxicol; 2011 Mar; 86(3):302-6. PubMed ID: 21312029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.